title: Olanzapine elevation of serum creatine kinase.
authors.forename: Ezequiel
authors.initials: E
authors.lastname: Martí-Bonmatí
authors.forename: Eva
authors.initials: E
authors.lastname: San Valero-Carcelén
authors.forename: María Pilar
authors.initials: MP
authors.lastname: Ortega-García
authors.forename: Ricardo
authors.initials: R
authors.lastname: Rubini-Puig
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000494:pharmacology; D001569:Benzodiazepines; D003402:Creatine Kinase / Q000097:blood*; D052279:Creatine Kinase, MB Form; D003937:Diagnosis, Differential; D006801:Humans; D007527:Isoenzymes / Q000097:blood; D008297:Male; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000097:blood / Q000175:diagnosis / Q000201:enzymology; D000077152:Olanzapine; D010890:Pirenzepine / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000494:pharmacology; D013268:Stimulation, Chemical
chemical_list: D014150:Antipsychotic Agents; D007527:Isoenzymes; D001569:Benzodiazepines; D010890:Pirenzepine; D003402:Creatine Kinase; D052279:Creatine Kinase, MB Form; D000077152:Olanzapine